Antidepressant PredictAR

Antidepressant PredictAR indetifies common genetic variants in both CYP2D6 and CYP2C19 genes that can alter a patients ability to metabolise certain antidepressants. This knowledge should help avoid long periods of trial and error when it comes to antidepressant medication, thereby improving efficacy and safety.

  Benefits of Using Antidepressant PredictAR

• Know your patients ability to metabolise antidepressants before treatment begins
• Identify which patients are at risk of medication intolerance.
• Identify which patients are at risk of medication failure.

Antidepressants not metabolised by CYP2D6         (Preferred in CYP2D6 Poor Metabolisers & Ultra-rapid Metabolisers)

Avanza, Cipramil, Lexapro & Zoloft

Antidepressants not metabolised by CYP2C19       (Preferred in CYP2C19 Poor Metabolisers)

Aropax, Avanza, Efexor & Zoloft